安赫多尼亚需要MC4R介导的突触适应在核中
Byung Kook Lim1, Kee Wui Huang, Brad A Grueter
1Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford, California 94305, USA.
Nature
|July 13, 2012
概括
慢性压力会通过削弱大脑中的突触触发抑郁症. 阻断黑色皮质素4受体通路可以防止压力诱导的无情感,揭示了抑郁症的关键机制.
科学领域:
- 神经科学是一个神经科学.
- 分子精神病学分子精神病学
- 行为神经科学 行为神经科学
背景情况:
- 慢性压力是人类抑郁症的主要危险因素,导致无情和行为绝望等症状.
- 压力诱导抑郁症背后的大脑电路中精确的突触适应仍然不清楚.
- 动物模型对于理解抑郁症的神经基础至关重要.
研究的目的:
- 在小鼠中调查潜在的慢性压力诱导抑郁症状的突触机制.
- 确定黑色皮质素4受体通路在压力诱导的无情症中的作用.
- 为了区分神经适应调解无情与行为绝望的神经适应.
主要方法:
- 在小鼠中利用了慢性压力范式.
- 检查了核中枢中枢中枢中枢中枢中枢中枢中枢中枢中枢中枢中枢中枢中的突触可塑性.
- 测量行为结果,包括无情和行为绝望.
- 在体内研究了阻断黑色皮质素4受体信号传递的效果.
主要成果:
- 慢性压力降低了D1多巴胺受体表达核accumbens神经元上的刺激性突触强度.
- 这种突触衰弱是由黑色皮质素4受体激活的介导.
- 阻止这些受体介导的突触变化可以防止压力诱导的无情感,但不能阻止行为绝望.
- 显著的神经适应可能是不同抑郁症状的基础.
结论:
- 压力引起的无神经是依赖于神经驱动的,细胞类型特异的突触变化在核 accumbens.
- 梅拉诺科丁4受体信号传递是压力诱导的无情感的关键调解者.
- 不同的神经回路和适应可能控制抑郁症的不同症状.
相关概念视频
Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


